Skip to main content
12 April 2021
Last updated:
Monday 12 April 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
  • Research Directory
  • Contact Us

News - Appointments

Marty Duvall appointed CEO at Oncopeptides

Sunday 2 August 2020
Company
Oncopeptides AB
Appointee Name
Marty 
Duvall

The Swedish pharmaceutical company Oncopeptides AB has announced the appointment of Marty Duvall as chief executive.

Country

Sweden

  • Read more about Marty Duvall appointed CEO at Oncopeptides

Marie Svensson to join Alligator Bioscience as CFO

Sunday 2 August 2020
Company
Alligator Bioscience AB
Appointee Name
Marie 
Svensson

Marie Svensson is to join the Swedish biotechnology company Alligator Bioscience AB as chief financial officer on 1 September.

Country

Sweden

  • Read more about Marie Svensson to join Alligator Bioscience as CFO

Kiadis appoints new CBO and new head of innovation

Sunday 19 July 2020
Company
Kiadis Pharma NV
Appointee Name
Ray Barlow and 
Govert Schouten

Kiadis Pharma NV has appointed Ray Barlow as chief business officer and Govert Schouten as head of innovation to help advance the company’s cell therapies for the treatment of liquid and solid tumours.

Country

Netherlands

  • Read more about Kiadis appoints new CBO and new head of innovation

Claude Knopf becomes CBO at ImCheck

Friday 10 July 2020
Company
ImCheck Therapeutics SAS
Appointee Name
Claude 
Knopf

Claude Knopf, a former Novartis executive, has joined ImCheck Therapeutics SAS of Marseille, France as chief business officer. He will be located in Boston, US. ImCheck is developing antibody drug candidates targeting the butyrophilin superfamily of immune system regulators.

Country

France

  • Read more about Claude Knopf becomes CBO at ImCheck

Edwin Moses becomes chair of Sensorion SA

Wednesday 8 July 2020
Company
Sensorion SA
Appointee Name
Edwin 
Moses

Edwin Moses, the former chief executive of Ablynx, has been appointed chair of the board of directors of Sensorion SA, a developer of treatments for hearing loss disorders. Dr Moses led Ablynx for more than 14 years until its acquisition by Sanofi SA in 2018.

Country

France

  • Read more about Edwin Moses becomes chair of Sensorion SA

Josefin-Beate Holz becomes CMO at Storm Therapeutics

Thursday 25 June 2020
Company
Storm Therapeutics Ltd
Appointee Name
Josefin-Beate 
Holz

Josefin-Beate Holz, an experienced drug developer, has joined Storm Therapeutics Ltd as chief medical officer to help advance the company’s small molecule therapies modulating RNA epigenetics.

Country

United Kingdom

  • Read more about Josefin-Beate Holz becomes CMO at Storm Therapeutics

Compass Pathways recruits Trevor Mill to head development

Thursday 25 June 2020
Company
Compass Pathways Ltd
Appointee Name
Trevor 
Mill

Compass Pathways Ltd has recruited Trevor Mill from Biogen Inc to lead the research and development of its psilocybin therapy for treatment-resistant depression and other projects. At Biogen he was head of global safety and regulatory sciences.

Country

United Kingdom

  • Read more about Compass Pathways recruits Trevor Mill to head development

Matthew Gall becomes CFO of iTeos Therapeutics

Thursday 25 June 2020
Company
iTeos Therapeutics Inc
Appointee Name
Matthew Gall, Yvonne McGrath and  
Philippe Brantegem

Matthew Gall, an industry veteran, has joined iTeos Therapeutics Inc as chief financial officer to help advance the company’s early-stage immuno-oncology portfolio.

Country

Belgium

  • Read more about Matthew Gall becomes CFO of iTeos Therapeutics

Ann Rhoads joins board of iTeos

Saturday 20 June 2020
Company
iTeos Therapeutics SA
Appointee Name
Ann 
Rhoads

Ann Rhoads, an experienced financial executive, has been appointed to the board of directors of iTeos Therapeutics SA, a Belgium-based immuno-oncology company.

Country

Belgium

  • Read more about Ann Rhoads joins board of iTeos

Pierre-Alain Ruffieux becomes CEO at Lonza

Saturday 20 June 2020
Company
Lonza Group AG
Appointee Name
Pierre-Alain 
Ruffieux

The Swiss chemicals and biotechnology company Lonza Group AG has appointed Pierre-Alain Ruffieux, currently head of global pharma technical operations at Roche, as its new chief executive. Dr Ruffie

Country

Switzerland

  • Read more about Pierre-Alain Ruffieux becomes CEO at Lonza

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page next ›
  • Last page last »

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

René Hoet becomes CSO at Montis Biosciences
Wednesday March 31 2021
Pan Cancer T makes board appointments
Wednesday March 31 2021
Björn Englund appointed CEO at Opterion
Wednesday March 31 2021
Sven Zimmermann joins Inotrem
Wednesday March 31 2021
New director at Mission Therapeutics
Wednesday March 31 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.